LRX712

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LRX712, covering 2026-01-07 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of Multiple Intra-articular Injections of LRX712 in Patients With Knee OA [Phase 2]

See pricing